the cliff
Patent cliff
Drugs ranked by the soonest barrier to generic / biosimilar entry. Each row shows the earliest-expiring patent OR FDA exclusivity for that drug — whichever falls first determines when competitive pressure begins.
- Aug 31, 20304.1ypatentBETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATEPerrigo New York Inc
- Sep 1, 20304.1ypatentLUMISIGHTPEGULICIANINELUMICELL
- Sep 21, 20304.2ypatentCeftaroline Fosamilceftaroline fosamilApotex Corp
- Sep 22, 20304.2ypatentGLYCEROL PHENYLBUTYRATEGLYCEROL PHENYLBUTYRATELupin Ltd
- Sep 25, 20304.2yNCEInluriyoimlunestrant tosylateEli Lilly and Co
- Sep 25, 20304.2yNCEPalsonifypaltusotine hydrochloride$CRNXCrinetics Pharmaceuticals, Inc.
- Sep 30, 20304.2yNCERhapsidoremibrutinib$NVSNOVARTIS AG
- Oct 1, 20304.2ypatentAmzeeqminocycline$DERMJourney Medical Corp
- Oct 27, 20304.3ypatentJevtanacabazitaxelSanofi-Aventis US LLC
- Nov 3, 20304.3yNCEKygevvi(doxecitine + doxribtimine)UCB SA
- Nov 13, 20304.3yNCEKomziftiziftomenib$KURAKura Oncology, Inc.
- Nov 18, 20304.4ypatentAkynzeo(fosnetupitant chloride hydrochloride + palonosetron hydrochloride)Helsinn Therapeutics (US) Inc
- Nov 19, 20304.4yNCEHyrnuosevabertinibBayer AG
- Nov 24, 20304.4ypatentEliglustat Tartrateeliglustat tartrateAizant Drug Research Solutions Pvt Ltd
- Dec 1, 20304.4ypatentLanthanum Carbonatelanthanum carbonateBarr Laboratories Inc
- Dec 6, 20304.4ypatentRenvelasevelamer carbonateSanofi-Aventis US LLC
- Dec 14, 20304.4ypatentAXPAXLIaxitinib$OCULOCULAR THERAPEUTIX, INC
- Dec 19, 20304.4yNCEMyqorzoaficamten$CYTKCYTOKINETICS INC
- Dec 30, 20304.5yNCENereustradipitant$VNDAVanda Pharmaceuticals Inc.
- Jan 12, 20314.5yNCEZycubocopper histidinateSentynl Therapeutics Inc
- Jan 14, 20314.5ypatentPliaglis(lidocaine + tetracaine)Taro Pharmaceutical USA Inc
- Jan 19, 20314.5ypatentZypitamagpitavastatin [INN]$MCUJFMEDICURE INC
- Jan 20, 20314.5ypatentPradaxadabigatran etexilate mesylateBoehringer Ingelheim Corp
- Jan 26, 20314.5ypatentInvega Sustennapaliperidone palmitateJohnson & Johnson Innovative Medicine
- Feb 4, 20314.6ypatentVocabriacabotegravir sodiumViiV Healthcare Company
- Mar 2, 20314.6ypatentLevomilnacipran Hydrochloridelevomilnacipran hydrochloridePrinston Pharmaceutical Inc
- Mar 10, 20314.7ypatentBarhemsysamisulpride [INN]Acacia Pharma Group Ltd
- Apr 3, 20314.7ypatentAustedo XRdeutetrabenazineTeva Neuroscience Inc
- Apr 30, 20314.8ypatentYuviwelnavepegritideAscendis Pharma AS
- May 18, 20314.9ypatentSolifenacin Succinatesolifenacin succinateNovadoz Pharmaceuticals LLC
- Jun 11, 20314.9ypatentSunosisolriamfetol hydrochloride$AXSMAxsome Therapeutics, Inc.
sourced from FDA Orange Book · approved drugs only · biologics + biosimilars excluded (those live in the Purple Book — coming soon)